GNMX

OTHER

Medgenics Inc

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving GNMX Today?

No stock-specific AI insight has been generated for GNMX yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$13M

P/E Ratio—

EPS$-0.35

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding65.0M

GNMX News

No news articles found for GNMX yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$0.00

52 Week Low$0.00

Fundamentals

Market Cap$13M

P/E Ratio—

EPS$-0.35

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding65.0M

About Medgenics Inc

Aevi Genomic Medicine, Inc., a clinical-stage biopharmaceutical company, researches and develops novel therapies for pediatric-onset and life-altering diseases in the United States. The company is headquartered in Wayne, Pennsylvania.

aevigenomics.com

Listed April 8, 2011

OTHEROTHER

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICOTHER

CIK—

Composite FIGI—

Share Class FIGI—